pubmed-article:12105843 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:12105843 | lifeskim:mentions | umls-concept:C0018951 | lld:lifeskim |
pubmed-article:12105843 | lifeskim:mentions | umls-concept:C0002199 | lld:lifeskim |
pubmed-article:12105843 | lifeskim:mentions | umls-concept:C1442989 | lld:lifeskim |
pubmed-article:12105843 | lifeskim:mentions | umls-concept:C0439831 | lld:lifeskim |
pubmed-article:12105843 | lifeskim:mentions | umls-concept:C0301625 | lld:lifeskim |
pubmed-article:12105843 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:12105843 | pubmed:dateCreated | 2002-7-9 | lld:pubmed |
pubmed-article:12105843 | pubmed:abstractText | Treatment of chronic hepatitis C with interferon (IFN)-alpha often has hematotoxic effects. We evaluated the effects of acute vs. chronic and standard vs. pegylated IFN-alpha on hematopoiesis. | lld:pubmed |
pubmed-article:12105843 | pubmed:language | eng | lld:pubmed |
pubmed-article:12105843 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12105843 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:12105843 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12105843 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12105843 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12105843 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12105843 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12105843 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12105843 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12105843 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12105843 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:12105843 | pubmed:month | Jul | lld:pubmed |
pubmed-article:12105843 | pubmed:issn | 0016-5085 | lld:pubmed |
pubmed-article:12105843 | pubmed:author | pubmed-author:JessnerWolfga... | lld:pubmed |
pubmed-article:12105843 | pubmed:author | pubmed-author:GanglAlfredA | lld:pubmed |
pubmed-article:12105843 | pubmed:author | pubmed-author:Peck-Radosavl... | lld:pubmed |
pubmed-article:12105843 | pubmed:author | pubmed-author:FerenciPeterP | lld:pubmed |
pubmed-article:12105843 | pubmed:author | pubmed-author:HoferHaraldH | lld:pubmed |
pubmed-article:12105843 | pubmed:author | pubmed-author:WichlasMartin... | lld:pubmed |
pubmed-article:12105843 | pubmed:author | pubmed-author:Homoncik-Kram... | lld:pubmed |
pubmed-article:12105843 | pubmed:author | pubmed-author:KreilAnnaA | lld:pubmed |
pubmed-article:12105843 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:12105843 | pubmed:volume | 123 | lld:pubmed |
pubmed-article:12105843 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:12105843 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:12105843 | pubmed:pagination | 141-51 | lld:pubmed |
pubmed-article:12105843 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
pubmed-article:12105843 | pubmed:meshHeading | pubmed-meshheading:12105843... | lld:pubmed |
pubmed-article:12105843 | pubmed:meshHeading | pubmed-meshheading:12105843... | lld:pubmed |
pubmed-article:12105843 | pubmed:meshHeading | pubmed-meshheading:12105843... | lld:pubmed |
pubmed-article:12105843 | pubmed:meshHeading | pubmed-meshheading:12105843... | lld:pubmed |
pubmed-article:12105843 | pubmed:meshHeading | pubmed-meshheading:12105843... | lld:pubmed |
pubmed-article:12105843 | pubmed:meshHeading | pubmed-meshheading:12105843... | lld:pubmed |
pubmed-article:12105843 | pubmed:meshHeading | pubmed-meshheading:12105843... | lld:pubmed |
pubmed-article:12105843 | pubmed:meshHeading | pubmed-meshheading:12105843... | lld:pubmed |
pubmed-article:12105843 | pubmed:meshHeading | pubmed-meshheading:12105843... | lld:pubmed |
pubmed-article:12105843 | pubmed:meshHeading | pubmed-meshheading:12105843... | lld:pubmed |
pubmed-article:12105843 | pubmed:meshHeading | pubmed-meshheading:12105843... | lld:pubmed |
pubmed-article:12105843 | pubmed:meshHeading | pubmed-meshheading:12105843... | lld:pubmed |
pubmed-article:12105843 | pubmed:meshHeading | pubmed-meshheading:12105843... | lld:pubmed |
pubmed-article:12105843 | pubmed:meshHeading | pubmed-meshheading:12105843... | lld:pubmed |
pubmed-article:12105843 | pubmed:meshHeading | pubmed-meshheading:12105843... | lld:pubmed |
pubmed-article:12105843 | pubmed:meshHeading | pubmed-meshheading:12105843... | lld:pubmed |
pubmed-article:12105843 | pubmed:meshHeading | pubmed-meshheading:12105843... | lld:pubmed |
pubmed-article:12105843 | pubmed:year | 2002 | lld:pubmed |
pubmed-article:12105843 | pubmed:articleTitle | Rapid suppression of hematopoiesis by standard or pegylated interferon-alpha. | lld:pubmed |
pubmed-article:12105843 | pubmed:affiliation | Department of Gastroenterology and Hepatology, University of Vienna, Vienna, Austria. markus.peck@akh-wien.ac.at | lld:pubmed |
pubmed-article:12105843 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12105843 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12105843 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12105843 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12105843 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12105843 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12105843 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12105843 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12105843 | lld:pubmed |